Refractory Alopecia Areata and Vitiligo Responding to Tofacitinib Monotherapy
INTRODUCTION
Tofacitinib is a Janus kinase (JAK) 1-3 inhibitor first U.S. Food and Drug Administration (FDA) approved in 2012 for rheumatoid arthritis, with subsequent approval for psoriatic arthritis, ulcerative colitis, polyarticular course juvenile idiopathic arthritis, and ankylosing spondylitis in 2017, 2018, 2020, and 2021, respectively.1,2 In the last several years, oral tofacitinib …
INTRODUCTION
Tofacitinib is a Janus kinase (JAK) 1-3 inhibitor first U.S. Food and Drug Administration (FDA) approved in 2012 for rheumatoid arthritis, with subsequent approval for psoriatic arthritis, ulcerative colitis, polyarticular course juvenile idiopathic arthritis, and ankylosing spondylitis in 2017, 2018, 2020, and 2021, respectively.1,2 In the last several years, oral tofacitinib … Continue reading "Refractory Alopecia Areata and Vitiligo Responding to Tofacitinib Monotherapy"
DID YOU KNOW?
Glycerin is among the most popular ingredients in beauty products, behind water and fragrance.1 With a 50+ year history of use, glycerin is a deceptively simple molecule classified as a powerful humectant that is anything but basic.
Glycerin is recognized by the U.S. Food & Drug Administration (FDA) as an over-the-counter skin protectant when used between 20-45%.2
… 
This month’s Patient Buzz includes articles that sought to predict the top skincare trends for 2023.
Are you in the know about the latest trends? Peruse this list of dermatology articles in the consumer press:
Allure: Cardi B has butt injections removed
Allure: Neuromodulator guide
Allure: Skincare trends for 2023
BestLife/Yahoo! Life: Skincare after 50
CNET: Good skin … 
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. George Han (Vice President of the Dermatologic Society of Greater New York, member of the board of directors of the New York State Society of Dermatology and Dermatologic Surgery, and member of the Medical Board of the National Psoriasis Foundation), who offers tips on better directing pa … 
How to treat acne scars is a popular topic in the consumer press this month. Online articles discussed the benefits and limitations of both chemical peels and scar creams.
What advice is your acne patients reading about fading their acne scars and post-inflammatory hyperpigmentation? Find out by reviewing this list of articles about hot dermatology topics in the consumer press:
Allur … 